Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Jun;55(6):589–594. doi: 10.1038/bjc.1987.120

Natural killer activity of lymphocytic infiltrates in mouse mammary lesions.

W Z Wei, G Heppner
PMCID: PMC2002039  PMID: 3620299

Abstract

Tissue infiltrating lymphocytes were isolated from BALB/c line C4 preneoplastic hyperplastic alveolar nodules (HAN) and spontaneous tumours that arose from the HANs. NK activity of the lymphocytic infiltrates was tested in a 4 h chromium release assay using 51Cr labelled YAC cells. In situ lymphocytes of C4 HAN expressed 3-4 fold greater relative lytic activity (Pross et al., 1981) than did normal spleen cells whereas the relative lytic activity of C4 tumour infiltrates was equivalent or less than that of normal spleen cells. Spleen cells of all lesion bearers had reduced cytolytic capacity. YAC cell lysis by spleen cells and HAN infiltrates correlated with increasing E/T ratios. The degree of YAC lysis by C4 tumour infiltrates, however, either decreased, stayed the same, or increased non-exponentially with increasing E/T ratios especially at E/T greater than 50. Indeed, C4 tumour infiltrates from animals pretreated with anti-asialo GM1 (ASGM) could suppress the NK activity of normal spleen cells. The lytic activity of both C4 HAN and tumour infiltrates could be enhanced or depressed by in vivo treatment with poly IC or anti-ASGM, respectively. These results indicate that NK cells are activated or recruited into C4 preneoplastic lesions but their lytic activity wanes and suppressive activity arises with progression to neoplasia.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlozzari T., Leonhardt J., Wiltrout R. H., Herberman R. B., Reynolds C. W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol. 1985 Apr;134(4):2783–2789. [PubMed] [Google Scholar]
  2. Blazar B. A., Laing C. A., Miller F. R., Heppner G. H. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays. J Natl Cancer Inst. 1980 Aug;65(2):405–410. [PubMed] [Google Scholar]
  3. Blazar B. A., Vanky F., Klein E. Purified mouse mammary tumor and lymphoid cells in immune assays. Cancer Immunol Immunother. 1984;18(3):174–178. doi: 10.1007/BF00205508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buckler C. E., DuBuy H. G., Johnson M. L., Baron S. Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. Proc Soc Exp Biol Med. 1971 Feb;136(2):394–398. doi: 10.3181/00379727-136-35272. [DOI] [PubMed] [Google Scholar]
  5. Buessow S. C., Paul R. D., Miller A. M., Lopez D. M. Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocarcinoma. I. Characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity. Int J Cancer. 1984 Jan 15;33(1):79–85. doi: 10.1002/ijc.2910330114. [DOI] [PubMed] [Google Scholar]
  6. Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979 Jan;122(1):175–181. [PubMed] [Google Scholar]
  7. Duwe A. K., Werkmeister J., Roder J. C., Lauzon R., Payne U. Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step. J Immunol. 1985 Apr;134(4):2637–2644. [PubMed] [Google Scholar]
  8. Eremin O., Coombs R. R., Ashby J. Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br J Cancer. 1981 Aug;44(2):166–176. doi: 10.1038/bjc.1981.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Farram E., Targan S. R. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing. J Immunol. 1983 Mar;130(3):1252–1256. [PubMed] [Google Scholar]
  10. Field A. K., Tytell A. A., Lampson G. P., Hilleman M. R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1004–1010. doi: 10.1073/pnas.58.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fulton A. M., Loveless S. E., Heppner G. H. Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA 100. Cancer Res. 1984 Oct;44(10):4308–4311. [PubMed] [Google Scholar]
  12. Gerson J. M., Tagliabue A., Herberman R. B. Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice. J Reticuloendothel Soc. 1981 Jan;29(1):15–21. [PubMed] [Google Scholar]
  13. Herberman R. B., Ortaldo J. R. Natural killer cells: their roles in defenses against disease. Science. 1981 Oct 2;214(4516):24–30. doi: 10.1126/science.7025208. [DOI] [PubMed] [Google Scholar]
  14. Johnson C. W., Wei W. Z., Barth R. F., Tuttle S. E., Andrews C. A. Monoclonal antibodies directed against preneoplastic and neoplastic murine mammary lesions. Cancer Res. 1985 Aug;45(8):3774–3781. [PubMed] [Google Scholar]
  15. Kasahara T., Djeu J. Y., Dougherty S. F., Oppenheim J. J. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol. 1983 Nov;131(5):2379–2385. [PubMed] [Google Scholar]
  16. Kasai M., Iwamori M., Nagai Y., Okumura K., Tada T. A glycolipid on the surface of mouse natural killer cells. Eur J Immunol. 1980 Mar;10(3):175–180. doi: 10.1002/eji.1830100304. [DOI] [PubMed] [Google Scholar]
  17. Kasai M., Yoneda T., Habu S., Maruyama Y., Okumura K., Tokunaga T. In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature. 1981 May 28;291(5813):334–335. doi: 10.1038/291334a0. [DOI] [PubMed] [Google Scholar]
  18. Loveless S. E., Heppner G. H. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors. J Immunol. 1983 Oct;131(4):2074–2078. [PubMed] [Google Scholar]
  19. Medina D. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice. J Natl Cancer Inst. 1976 Nov;57(5):1185–1189. doi: 10.1093/jnci/57.5.1185. [DOI] [PubMed] [Google Scholar]
  20. Millard P. J., Henkart M. P., Reynolds C. W., Henkart P. A. Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors. J Immunol. 1984 Jun;132(6):3197–3204. [PubMed] [Google Scholar]
  21. Moore M. Natural immunity to tumours--theoretical predictions and biological observations. Br J Cancer. 1985 Aug;52(2):147–151. doi: 10.1038/bjc.1985.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Parthenais E., Haskill S. Immunity to the T1699 murine mammary tumor. II. Thymic influence on the in situ inflammatory response, metastatic growth and invasiveness. J Immunol. 1979 Sep;123(3):1334–1338. [PubMed] [Google Scholar]
  23. Pizzolo G., Semenzato G., Chilosi M., Morittu L., Ambrosetti A., Warner N., Bofill M., Janossy G. Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions. Clin Exp Immunol. 1984 Jul;57(1):195–206. [PMC free article] [PubMed] [Google Scholar]
  24. Pross H. F., Baines M. G., Rubin P., Shragge P., Patterson M. S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol. 1981 Jan;1(1):51–63. doi: 10.1007/BF00915477. [DOI] [PubMed] [Google Scholar]
  25. Ruppert B., Blazar B., Medina D., Heppner G. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice. J Immunol. 1979 Jun;122(6):2180–2183. [PubMed] [Google Scholar]
  26. Ruppert B., Wei W., Medina D., Heppner G. H. Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines. J Natl Cancer Inst. 1978 Oct;61(4):1165–1169. [PubMed] [Google Scholar]
  27. Scala G., Allavena P., Djeu J. Y., Kasahara T., Ortaldo J. R., Herberman R. B., Oppenheim J. J. Human large granular lymphocytes are potent producers of interleukin-1. Nature. 1984 May 3;309(5963):56–59. doi: 10.1038/309056a0. [DOI] [PubMed] [Google Scholar]
  28. Stutman O. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer. Cancer Res. 1976 Feb;36(2 Pt 2):739–747. [PubMed] [Google Scholar]
  29. Wei W. Z., Malone K., Mahoney K., Heppner G. Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues. Cancer Res. 1986 Jun;46(6):2680–2685. [PubMed] [Google Scholar]
  30. Wei W. Z., Miller F. R., Blazar B. A., Medina D., Heppner G. Opposing effects of cryostat sections of preneoplastic and neoplastic mouse mammary lesions on in vitro migration of peritoneal exudate cells. J Immunol. 1979 May;122(5):2059–2067. [PubMed] [Google Scholar]
  31. Wiltrout R. H., Herberman R. B., Zhang S. R., Chirigos M. A., Ortaldo J. R., Green K. M., Jr, Talmadge J. E. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol. 1985 Jun;134(6):4267–4275. [PubMed] [Google Scholar]
  32. Wright S. C., Bonavida B. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells. J Immunol. 1982 Jul;129(1):433–439. [PubMed] [Google Scholar]
  33. Yamashina K., Miller B. E., Heppner G. H. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. Cancer Res. 1986 May;46(5):2396–2401. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES